Cargando…
Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes
Viral diversity is a challenge to the development of a hepatitis C virus (HCV) vaccine. Following vaccination of humans with adenoviral vectors, we determined the capacity of T cells to target common viral variants at immundominant epitopes ex vivo. We identified two major variants for epitopes NS3(...
Autores principales: | Kelly, Christabel, Swadling, Leo, Brown, Anthony, Capone, Stefania, Folgori, Antonella, Salio, Mariolina, Klenerman, Paul, Barnes, Eleanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784727/ https://www.ncbi.nlm.nih.gov/pubmed/25263407 http://dx.doi.org/10.1002/eji.201444686 |
Ejemplares similares
-
Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure
por: Hartnell, Felicity, et al.
Publicado: (2020) -
Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
por: Capone, Stefania, et al.
Publicado: (2020) -
Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8(+) T Cells by Persistent Viruses and Vaccines
por: Gordon, Claire Louse, et al.
Publicado: (2018) -
Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
por: Kelly, Christabel, et al.
Publicado: (2016) -
A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein
por: Huang, Jiachen, et al.
Publicado: (2022)